Trial · NCT01526408
Famvir for Treatment of Hearing in Unilateral Meniere's Disease
NCT01526408, Phase 3, Terminated, House Research Institute; results first posted 2021-04-19
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Famvir for Treatment of Hearing in Unilateral Meniere's Disease. Trials, record NCT01526408. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01526408
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Famvir for Treatment of Hearing in Unilateral Meniere's Disease
- NCT number
- NCT01526408
- Status
- Terminated
- Phases
- Phase 3
- Enrollment
- 11 participants, actual
- Lead sponsor
- House Research Institute
- Conditions
- Meniere's Disease
- Interventions
- Famciclovir, Placebo
- First posted
- 2012-02-03
- Last updated
- 2021-04-19
- Results first posted
- 2021-04-19
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pure-tone Threshold Change | 3 months | Change in hearing from baseline to after 3 months of treatment |
| Secondary | Tinnitus and/or Dizziness Handicap Change | 3 months | Change in tinnitus and/or dizziness from baseline to after 3 months of treatment |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Pure-tone Threshold Change | 3 months | early termination of study and sponsor organization closed | ||
| SECONDARY | Tinnitus and/or Dizziness Handicap Change | 3 months | early termination of study and sponsor organization closed |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Placebo Arm | 0 | |
| Overall Study | STARTED | Active Arm | 0 | |
| Overall Study | COMPLETED | Placebo Arm | 0 | |
| Overall Study | COMPLETED | Active Arm | 0 | |
| Overall Study | NOT COMPLETED | Placebo Arm | 0 | |
| Overall Study | NOT COMPLETED | Active Arm | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Placebo Arm | 0 | 0 |
| Total, all-cause mortality | Active Arm | 0 | 0 |
| Total, other adverse events | Placebo Arm | 0 | 0 |
| Total, other adverse events | Active Arm | 0 | 0 |
| Total, serious adverse events | Placebo Arm | 0 | 0 |
| Total, serious adverse events | Active Arm | 0 | 0 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01526408
GET https://conductscience.org/api/trials/v1/NCT01526408/registered